102
Views
2
CrossRef citations to date
0
Altmetric
Articles

Immunoglobulin G amplifies the production of regulatory rheumatoid factor in vitro through idiotype-anti-idiotype interactions

, , , , , , , & show all

References

  • Heyman, B. Regulation of Antibody Responses via Antibodies, Complement, and Fc Receptors. Annu. Rev. Immunol. 2000, 18, 709–737. DOI: 10.1146/annurev.immunol.18.1.709.
  • Hjelm, F.; Carlsson, F.; Getahun, A.; Heyman, B. Antibody-mediated Regulation of the Immune Response. Scand J. Immunol. 2006, 64, 177–184. DOI: 10.1111/sji.2006.64.issue-3.
  • Schulz, R.; Werner, B.; Behn, U. Self-tolerance in a Minimal Model of the Idiotypic Network. Front. Immunol. 2014, 5, 86.
  • Thomas-Vaslin, V. A Complex Immunological Idiotypic Network for Maintenance of Tolerance. Front. Immunol. 2014, 5, 369. DOI: 10.3389/fimmu.2014.00369.
  • Orange, J. S. Use of Intravenous Immunoglobulin in Human Disease: A Review of Evidence by Members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J. Allergy Clin. Immunol. 2006, 117, 525–553. DOI: 10.1016/j.jaci.2006.01.015.
  • Mulhearn, B.; Bruce, I. N. Indications for IVIG in Rheumatic Diseases. Rheumatology. 2015, 54, 383–391. DOI: 10.1093/rheumatology/keu429.
  • Katz, U.; Shoenfeld, Y.; Zandman-Goddard, G. Update on Intravenous Immunoglobulins (Ivig) Mechanisms of Action and Off-Label Use in Autoimmune Diseases. Curr. Pharm. Des. 2011, 17, 3166–3175. DOI: 10.2174/138161211798157540.
  • Warncke, M.; Buchner, M.; Thaller, G.; Dodero, A.; Bulashevska, A.; Pfeifer, D.; Timmer, J.; Veelken, H. Control of the Specificity of T Cell-mediated Anti-idiotype Immunity by Natural Regulatory T Cells. Cancer Immunol. Immunother. 2011, 60, 49–60. DOI: 10.1007/s00262-010-0918-x.
  • Krieger, N. J.; Pesce, A.; Michael, J. G. Immunoregulation of the Anti-bovine Serum Albumin Response by Polyclonal and Monoclonal Antibodies. Cell. Immunol. 1983, 80, 279–287. DOI: 10.1016/0008-8749(83)90116-8.
  • Sidorov, A.; Beduleva, L.; Menshikov, I.; Terentiev, A.; Stolyarova, E.; Abisheva, N. Fc Fragments of Immunoglobulin G are an Inductor of Regulatory Rheumatoid Factor and a Promising Therapeutic Agent for Rheumatic Diseases. Int. J. Biol. Macromol. 2017, 95, 938–945. DOI: 10.1016/j.ijbiomac.2016.10.081.
  • Beduleva, L.; Menshikov, I.; Stolyarova, E.; Fomina, K.; Lobanova, O.; Ivanov, P.; Terentiev, A.; et al. Rheumatoid Factor in Idiotypic Regulation of Autoimmunity. Int. J. Rheum. Dis. 2015, 18, 408–420. DOI: 10.1111/apl.2015.18.issue-4.
  • Hozumi, K.; Masuko, T.; Nishimura, T.; Habu, S.; Hashimoto, Y. Characterization of the T Cells in Aged Rat Bone Marrow. Immunol. Lett. 1993, 36, 137–143. DOI: 10.1016/0165-2478(93)90045-4.
  • Stolyarova, E.; Beduleva, L.; Menshikov, I.; Sidorov, A.; Khramova, T. Lymphocyte Dependence of the Immune Response to Immunosuppressive Neoantigen-exposing Fc Fragments of IgG. J. Biol. Regul. Homeost. Agents. 2019, 33, 113–120.
  • Berman, M. A.; Weigle, W. O. B-lymphocytes Activation by the Fc Region of IgG. J. Exp. Med. 1977, 146, 241–256. DOI: 10.1084/jem.146.1.241.
  • Stolyarova, E.; Beduleva, L.; Menshikov, I.; Snigiryev, A.; Khramova, T. Mechanism by Which Regulatory Rheumatoid Factor Prevents Experimental Autoimmune Encephalomyelitis. Endocr. Metab. Immune Disord. Drug Targets. 2018, 18, 596–601. DOI: 10.2174/1871530318666180308123350.
  • Karlsson, M.; Getahun, A.; Heyman, B. FcgammaRIIB in IgG-mediated Suppression of Antibody Responses: Different Impact in Vivo and in Vitro. J. Immunol. 2001, 167, 5558–5564. DOI: 10.4049/jimmunol.167.10.5558.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.